Platelet lysate for expansion or osteogenic differentiation of bone marrow mesenchymal stem cells for 3D tissue constructs
Background: The use of mesenchymal stem cells (MSCs) for the development of tissue-engineered constructs has advanced in recent years. However, future clinically approved products require following good manufacturing practice (GMP) guidelines. This includes using alternatives to xenogeneic-derived c...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-12-01
|
Series: | Regenerative Therapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352320423000755 |
_version_ | 1797448077743751168 |
---|---|
author | Luis Oliveros Anerillas Mikael Wiberg Paul J. Kingham Peyman Kelk |
author_facet | Luis Oliveros Anerillas Mikael Wiberg Paul J. Kingham Peyman Kelk |
author_sort | Luis Oliveros Anerillas |
collection | DOAJ |
description | Background: The use of mesenchymal stem cells (MSCs) for the development of tissue-engineered constructs has advanced in recent years. However, future clinically approved products require following good manufacturing practice (GMP) guidelines. This includes using alternatives to xenogeneic-derived cell culture supplements to avoid rejection of the transplants. Consequently, human platelet lysate (PLT) has been adopted as an affordable and effective alternative to foetal bovine serum (FBS) in traditional 2D cultures. However, little is known about its effect in more advanced 3D culture systems. Methods: We evaluated bone marrow MSCs (BMSCs) proliferation and CD marker expression in cells expanded in FBS or PLT-supplemented media. Differentiation capacity of the BMSCs expanded in the presence of the different supplements was evaluated in 3D type I collagen hydrogels. Furthermore, the effects of the supplements on the process of differentiation were analyzed by using qPCR and histological staining. Results: Cell proliferation was greater in PLT-supplemented media versus FBS. BMSCs expanded in PLT showed similar osteogenic differentiation capacity in 3D compared with FBS expanded cells. In contrast, when cells were 3D differentiated in PLT they showed lower osteogenesis versus the traditional FBS protocol. This was also the case for adipogenic differentiation, in which FBS supplementation was superior to PLT. Conclusions: PLT is a superior alternative to FBS for the expansion of MSCs without compromising their subsequent differentiation capacity in 3D. However, differentiation in PLT is impaired. Thus, PLT can be used to reduce the time required to expand the necessary cell numbers for development of 3D tissue engineered MSC constructs. |
first_indexed | 2024-03-09T14:05:10Z |
format | Article |
id | doaj.art-cac198d770fd4a729c1e2776e6f67c72 |
institution | Directory Open Access Journal |
issn | 2352-3204 |
language | English |
last_indexed | 2024-03-09T14:05:10Z |
publishDate | 2023-12-01 |
publisher | Elsevier |
record_format | Article |
series | Regenerative Therapy |
spelling | doaj.art-cac198d770fd4a729c1e2776e6f67c722023-11-30T05:07:49ZengElsevierRegenerative Therapy2352-32042023-12-0124298310Platelet lysate for expansion or osteogenic differentiation of bone marrow mesenchymal stem cells for 3D tissue constructsLuis Oliveros Anerillas0Mikael Wiberg1Paul J. Kingham2Peyman Kelk3Department of Integrative Medical Biology, Umeå University, 901 87 Umeå, Sweden; Corresponding author.Department of Integrative Medical Biology, Umeå University, 901 87 Umeå, Sweden; Department of Surgical & Perioperative Sciences, Section for Hand and Plastic Surgery, Umeå University, 901 87 Umeå, SwedenDepartment of Integrative Medical Biology, Umeå University, 901 87 Umeå, SwedenDepartment of Integrative Medical Biology, Umeå University, 901 87 Umeå, Sweden; Corresponding author.Background: The use of mesenchymal stem cells (MSCs) for the development of tissue-engineered constructs has advanced in recent years. However, future clinically approved products require following good manufacturing practice (GMP) guidelines. This includes using alternatives to xenogeneic-derived cell culture supplements to avoid rejection of the transplants. Consequently, human platelet lysate (PLT) has been adopted as an affordable and effective alternative to foetal bovine serum (FBS) in traditional 2D cultures. However, little is known about its effect in more advanced 3D culture systems. Methods: We evaluated bone marrow MSCs (BMSCs) proliferation and CD marker expression in cells expanded in FBS or PLT-supplemented media. Differentiation capacity of the BMSCs expanded in the presence of the different supplements was evaluated in 3D type I collagen hydrogels. Furthermore, the effects of the supplements on the process of differentiation were analyzed by using qPCR and histological staining. Results: Cell proliferation was greater in PLT-supplemented media versus FBS. BMSCs expanded in PLT showed similar osteogenic differentiation capacity in 3D compared with FBS expanded cells. In contrast, when cells were 3D differentiated in PLT they showed lower osteogenesis versus the traditional FBS protocol. This was also the case for adipogenic differentiation, in which FBS supplementation was superior to PLT. Conclusions: PLT is a superior alternative to FBS for the expansion of MSCs without compromising their subsequent differentiation capacity in 3D. However, differentiation in PLT is impaired. Thus, PLT can be used to reduce the time required to expand the necessary cell numbers for development of 3D tissue engineered MSC constructs.http://www.sciencedirect.com/science/article/pii/S2352320423000755Foetal bovine serumHuman platelet lysateMesenchymal stem cellsOsteogenesis3D |
spellingShingle | Luis Oliveros Anerillas Mikael Wiberg Paul J. Kingham Peyman Kelk Platelet lysate for expansion or osteogenic differentiation of bone marrow mesenchymal stem cells for 3D tissue constructs Regenerative Therapy Foetal bovine serum Human platelet lysate Mesenchymal stem cells Osteogenesis 3D |
title | Platelet lysate for expansion or osteogenic differentiation of bone marrow mesenchymal stem cells for 3D tissue constructs |
title_full | Platelet lysate for expansion or osteogenic differentiation of bone marrow mesenchymal stem cells for 3D tissue constructs |
title_fullStr | Platelet lysate for expansion or osteogenic differentiation of bone marrow mesenchymal stem cells for 3D tissue constructs |
title_full_unstemmed | Platelet lysate for expansion or osteogenic differentiation of bone marrow mesenchymal stem cells for 3D tissue constructs |
title_short | Platelet lysate for expansion or osteogenic differentiation of bone marrow mesenchymal stem cells for 3D tissue constructs |
title_sort | platelet lysate for expansion or osteogenic differentiation of bone marrow mesenchymal stem cells for 3d tissue constructs |
topic | Foetal bovine serum Human platelet lysate Mesenchymal stem cells Osteogenesis 3D |
url | http://www.sciencedirect.com/science/article/pii/S2352320423000755 |
work_keys_str_mv | AT luisoliverosanerillas plateletlysateforexpansionorosteogenicdifferentiationofbonemarrowmesenchymalstemcellsfor3dtissueconstructs AT mikaelwiberg plateletlysateforexpansionorosteogenicdifferentiationofbonemarrowmesenchymalstemcellsfor3dtissueconstructs AT pauljkingham plateletlysateforexpansionorosteogenicdifferentiationofbonemarrowmesenchymalstemcellsfor3dtissueconstructs AT peymankelk plateletlysateforexpansionorosteogenicdifferentiationofbonemarrowmesenchymalstemcellsfor3dtissueconstructs |